Crystal Kincaid, DPM
Podiatrist · Winchester, KYNPI 1669500799
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Melinta Therapeutics, LLC at 31.1% of the total. Reporting peaked in 2019 at $179 and has fallen 78.5% since, to $39 in 2025. That places this record below the midpoint for podiatrist clinicians in KY, where the typical reported total is $436.
Across 20 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Melinta Therapeutics, LLC$95
- Smith+Nephew$82
- Stryker$22
- DJO, LLC$20
- AbbVie$20
- Nabriva Therapeutics, PLC$19
- plus $48 from 4 others
What the payments were for
- Food & beverage$306100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Melinta Therapeutics, LLC | 7 | $95 |
| Smith+Nephew | 5 | $82 |
| Stryker | 1 | $22 |
| DJO, LLC | 1 | $20 |
| AbbVie | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $19 |
| Derma Sciences, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Merck | 1 | $11 |
| Aroa Biosurgery Incorporated | 1 | $4 |
How this compares
$306 in reported general payments places this provider in the 45th percentile of 54 podiatrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 222 | $8,681 |
| Diclofenac Sodium | 55 | $1,567 |
| Ammonium Lactate | 66 | $1,283 |
| Nystatin | 100 | $1,127 |
| Mupirocin | 147 | $891 |
| Terbinafine Hcl | 52 | $346 |
| Clindamycin Hcl | 36 | $208 |
| Cephalexin | 35 | $144 |
| Levofloxacin | 28 | $74 |
| Doxycycline Hyclate | 20 | $69 |
| Triamcinolone Acetonide | 12 | $53 |
| Ciprofloxacin Hcl | 12 | $21 |
| Amoxicillin | 15 | $13 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Winchester
- Thomas ChildressLouisville$283K
- Joshua CogerLouisville$132K
- David SmithHopkinsville$66K
- Matthew FeltnerCampbellsville$38K
- Zachery WeyandtLouisville$37K
- Robert HerbstFlorence$24K
- Michael AllenLexington$24K
- Thomas PoynterDanville$20K
- Andrew BouwkampLouisville$19K
- Braxton RiderLouisville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.